Screener
Tandem Diabetes Care TNDM Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash used to settle withholding taxes on vested restricted stock, net of proceeds from issuance of common stock under Company stock plans | 458 | (3,641) |
| Net cash provided by (used in) financing activities | 276,315 | (44,401) |
| Effect of foreign exchange rate changes on cash | 2,229 | (263) |
| Net decrease in cash and cash equivalents | (27,816) | (5,122) |
| Cash and cash equivalents at beginning of period | 90,634 | 69,234 |
| Cash and cash equivalents at end of period | $62,818 | $64,112 |
| Supplemental disclosures of cash flow information | ||
| Income taxes (refunded) paid | $(1,758) | $4,892 |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's net change in cash?
- Tandem Diabetes Care (TNDM) reported net change in cash of -$116.51M in Q2 2026.
- What is the long-term trend for Tandem Diabetes Care's net change in cash?
- Over 3 years (2021 to 2024), Tandem Diabetes Care's net change in cash has grown at a -23.8% compound annual growth rate (CAGR), from -$23.43M to $10.37M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Tandem Diabetes Care's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude